Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight Adults
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to evaluate the safety and tolerability of single escalating
doses of Peptide YY3-36 and to determine effects on food intake and serum hormones when
administered by intravenous infusion to otherwise healthy overweight adult subjects.